Lucence Health Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| LIQUIK: LIQUId Biopsy for Detection of Actionable Genomic BiomarKers in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) (NCT04703153) | Lucence Health Inc. | 2021-04-05 |
Track Lucence Health Inc. automatically
Every clearance here is in the API, with alerts when new ones post.